HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicholas D Oakes Selected Research

Nicholas D Oakes Research Topics

Disease

8Insulin Resistance
10/2022 - 11/2002
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2002
2Glucose Intolerance
01/2017 - 10/2005
2Dyslipidemias (Dyslipidemia)
01/2017 - 04/2007
2Hypertriglyceridemia
01/2017 - 11/2002
2Hyperglycemia
01/2017 - 11/2002
2Cardiovascular Diseases (Cardiovascular Disease)
10/2005 - 11/2002
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2005 - 11/2002
1Inflammation (Inflammations)
10/2022
1Glycosuria
01/2022
1Ketosis
01/2022
1Body Weight (Weight, Body)
01/2014
1Obesity
01/2013
1Hyperlipidemias (Hyperlipidemia)
10/2005
1Hyperinsulinism (Hyperinsulinemia)
11/2002

Drug/Important Bio-Agent (IBA)

6Glucose (Dextrose)FDA LinkGeneric
10/2022 - 11/2002
4Insulin (Novolin)FDA Link
01/2022 - 07/2004
4LipidsIBA
01/2017 - 10/2005
3Fatty Acids (Saturated Fatty Acids)IBA
10/2017 - 11/2002
3Nonesterified Fatty Acids (NEFA)IBA
10/2017 - 07/2004
3tesaglitazarIBA
10/2005 - 11/2002
3PPAR alphaIBA
10/2005 - 11/2002
2pirinixic acidIBA
01/2014 - 04/2007
2Triglycerides (Triacylglycerol)IBA
04/2007 - 10/2005
1AZD1656IBA
10/2022
1Sodium-Glucose Transport ProteinsIBA
01/2022
1dapagliflozinIBA
01/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2022
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2022
1Ketone BodiesIBA
01/2022
1KetonesIBA
01/2022
1Therapeutic UsesIBA
10/2005
1CarbohydratesIBA
11/2002

Therapy/Procedure

1Glycemic Control
10/2022